BANK VONTOBEL/CALL/ROCHE GS/340/0.02/21.06.24 Share Price

Warrant

WROBUV

CH1225203087

Real-time Bid/Ask 09:25:02 17/05/2024 am IST
0.002 CHF / 0.01 CHF -40.00% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/340/0.02/21.06.24
Current year-50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBUV
ISINCH1225203087
Date issued 15/12/2022
Strike 340 CHF
Maturity 21/06/2024 (35 Days)
Parity 50 : 1
Emission price 0.21 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.22 CHF
Lowest since issue 0.01 CHF
Delta0.02x
Omega 16.51
Premium44.93x
Gearing782.67x
Moneyness 0.6906
Difference Strike 103.4 CHF
Difference Strike %+30.41%
Spread 0.008 CHF
Spread %80.00%
Theoretical value 0.006000
Implied Volatility 56.19 %
Total Loss Probability 98.63 %
Intrinsic value 0.000000
Present value 0.006000
Break even 340.30 CHF
Theta-0x
Vega0x
Rho0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.8 CHF
Average target price
279.4 CHF
Spread / Average Target
+18.99%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBUV Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW